Consolidated manufacturing volumes for Q3 FY25 remained stable at 132,187 KL, while for 9M FY25 it stood at 372,505 KL
AstraZeneca’s Phase III FLAURA2 trial shows positive result
Zhimeng Biopharma’s investigational drug approved to begin phase 2 epilepsy clinical trial in China
Yatharth Hospitals acquires Shantived Hospital in Agra for Rs. 260 Cr
Subscribe To Our Newsletter & Stay Updated
Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants
Implementing a digital transformation in chemical operations to maximize profitability
The complexity of compliance
The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation
The guiding role of fluidized and spouted bed technologies in particle building processes